Basic Science Research

PhD, Professor and Goltz Professor representing neurodermatology.

Dr.Wilcox's role in the department research program is to lead the development of neuroderm research. His strengths are that he has had decades of continuous NIH-funded research in neuropharmacology, has had one R21 on peripheral opioid synergy (pas) as well as $200,000 current internal funding for preclinical development of a peripheral opioid analgesic combination. Dr. Wilcox also has access to efficient behavioral and electrophysiological laboratories and new colony of "blue light nociceptor" mice for optogenetic studies of cutaneous pain and analgesia mechanisms. George's challenges include the submission of proteomics and peripheral analgesic papers that have been generated with the neurodermatology team, refunding a R01 with peripheral (skin) components and harmonizing his neuropharmacological mission with the neurodermatological mission.